Targeting tumors with nanobodies for cancer imaging and therapy
Sabrina Oliveira(Unknown), Paul M.P. van Bergen en Henegouwen(Utrecht University), Robbert J. Kok(Utrecht University), Raimond Heukers(Utrecht University), Jirawas Sornkom(Utrecht University)
Cited by 205
Related Papers
RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature
|Drug Resistance Updates|2005|461
Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
|Advanced Drug Delivery Reviews|2013|396
Diverse origins of the myofibroblast—implications for kidney fibrosis
|Nature Reviews Nephrology|2015|305
Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
|Clinical Cancer Research|2016|289
Strategies for encapsulation of small hydrophilic and amphiphilic drugs in PLGA microspheres: State-of-the-art and challenges
|International Journal of Pharmaceutics|2016|285